Tandem Diabetes Care Stock Price, News & Analysis (NASDAQ:TNDM)

$3.10 +0.11 (+3.68 %)
(As of 02/23/2018 03:48 AM ET)
Previous Close$2.99
Today's Range$2.87 - $3.32
52-Week Range$2.14 - $25.30
Volume2.31 million shs
Average Volume1.07 million shs
Market Capitalization$31.37 million
P/E Ratio-0.16
Dividend YieldN/A
Beta0.44

About Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care logoTandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Receive TNDM News and Ratings via Email

Sign-up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:TNDM
CUSIPN/A
Phone+1-858-3666900

Debt

Debt-to-Equity Ratio-2.70%
Current Ratio1.90%
Quick Ratio0.88%

Price-To-Earnings

Trailing P/E Ratio-0.157280568239472
Forward P/E Ratio-0.20
P/E GrowthN/A

Sales & Book Value

Annual Sales$84.25 million
Price / Sales1.48
Cash FlowN/A
Price / CashN/A
Book Value($1.90) per share
Price / Book-1.63

Profitability

Trailing EPS($19.71)
Net Income$-83,440,000.00
Net Margins-79.45%
Return on EquityN/A
Return on Assets-74.29%

Miscellaneous

Employees591
Outstanding Shares40,120,000

Tandem Diabetes Care (NASDAQ:TNDM) Frequently Asked Questions

What is Tandem Diabetes Care's stock symbol?

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

When did Tandem Diabetes Care's stock split? How did Tandem Diabetes Care's stock split work?

Tandem Diabetes Care shares reverse split on the morning of Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of Tandem Diabetes Care stock prior to the reverse split would have 10 shares after the split.

How were Tandem Diabetes Care's earnings last quarter?

Tandem Diabetes Care Inc (NASDAQ:TNDM) released its earnings results on Thursday, October, 26th. The medical device company reported ($3.09) EPS for the quarter, topping the consensus estimate of ($3.74) by $0.65. The medical device company earned $27 million during the quarter, compared to the consensus estimate of $25.92 million. The company's quarterly revenue was up 119.7% on a year-over-year basis. During the same period in the previous year, the company posted ($0.97) earnings per share. View Tandem Diabetes Care's Earnings History.

When will Tandem Diabetes Care make its next earnings announcement?

Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Wednesday, April, 25th 2018. View Earnings Estimates for Tandem Diabetes Care.

Where is Tandem Diabetes Care's stock going? Where will Tandem Diabetes Care's stock price be in 2018?

6 equities research analysts have issued twelve-month price objectives for Tandem Diabetes Care's stock. Their forecasts range from $3.00 to $17.00. On average, they anticipate Tandem Diabetes Care's stock price to reach $13.00 in the next twelve months. View Analyst Ratings for Tandem Diabetes Care.

Who are some of Tandem Diabetes Care's key competitors?

Who are Tandem Diabetes Care's key executives?

Tandem Diabetes Care's management team includes the folowing people:

  • Dick P. Allen, Independent Chairman of the Board (Age 72)
  • Kim D. Blickenstaff, President, Chief Executive Officer, Director (Age 64)
  • Leigh Vosseller, Chief Financial Officer, Senior Vice President
  • John F. Sheridan, Chief Operating Officer, Executive Vice President (Age 61)
  • David B. Berger Esq., Executive Vice President, General Counsel, Secretary (Age 47)
  • Brian B. Hansen, Chief Commercial Officer, Executive Vice President (Age 49)
  • Susan M. Morrison, Chief Administrative Officer (Age 37)
  • Edward L. Cahill, Independent Director (Age 61)
  • Fred E. Cohen Ph.D. M.D., Independent Director (Age 60)
  • Howard E. Greene Jr., Independent Director (Age 74)

Who owns Tandem Diabetes Care stock?

Tandem Diabetes Care's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Frontier Capital Management Co. LLC (4.67%) and Wasatch Advisors Inc. (2.75%). Company insiders that own Tandem Diabetes Care stock include Christopher J Twomey, Dick Allen, John F Sheridan and Kim D Blickenstaff. View Institutional Ownership Trends for Tandem Diabetes Care.

Who sold Tandem Diabetes Care stock? Who is selling Tandem Diabetes Care stock?

Tandem Diabetes Care's stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC and Wasatch Advisors Inc.. View Insider Buying and Selling for Tandem Diabetes Care.

How do I buy Tandem Diabetes Care stock?

Shares of Tandem Diabetes Care can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tandem Diabetes Care's stock price today?

One share of Tandem Diabetes Care stock can currently be purchased for approximately $3.10.

How big of a company is Tandem Diabetes Care?

Tandem Diabetes Care has a market capitalization of $31.37 million and generates $84.25 million in revenue each year. The medical device company earns $-83,440,000.00 in net income (profit) each year or ($19.71) on an earnings per share basis. Tandem Diabetes Care employs 591 workers across the globe.

How can I contact Tandem Diabetes Care?

Tandem Diabetes Care's mailing address is 11045 Roselle St Ste 200, SAN DIEGO, CA 92121-1231, United States. The medical device company can be reached via phone at +1-858-3666900 or via email at [email protected]


MarketBeat Community Rating for Tandem Diabetes Care (TNDM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  185 (Vote Outperform)
Underperform Votes:  213 (Vote Underperform)
Total Votes:  398
MarketBeat's community ratings are surveys of what our community members think about Tandem Diabetes Care and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tandem Diabetes Care (NASDAQ:TNDM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.332.44
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.00$13.00$13.00$50.83
Price Target Upside: 343.69% upside343.69% upside343.69% upside425.63% upside

Tandem Diabetes Care (NASDAQ:TNDM) Consensus Price Target History

Price Target History for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ:TNDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/19/2017Robert W. BairdReiterated RatingHold$3.00N/AView Rating Details
10/10/2017WedbushReiterated RatingOutperform$50.00 -> $17.00N/AView Rating Details
10/6/2017Piper Jaffray CompaniesReiterated RatingHold$15.00N/AView Rating Details
5/3/2017B. RileyReiterated RatingNeutral$15.00MediumView Rating Details
4/10/2017CowenDowngradeOutperform -> Market Perform$15.00MediumView Rating Details
3/9/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
11/2/2016Deutsche BankLower Price TargetBuy$140.00 -> $90.00N/AView Rating Details
11/2/2016Feltl & Co.DowngradeStrong-Buy -> BuyN/AView Rating Details
11/2/2016Stifel NicolausDowngradeBuy -> Hold$150.00 -> $35.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
3/24/2016Bank of AmericaDowngradeNeutral -> UnderperformN/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Tandem Diabetes Care (NASDAQ:TNDM) Earnings History and Estimates Chart

Earnings by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ TNDM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018N/AView Earnings Details
10/26/2017Q3 2017($3.74)($3.09)$25.92 million$27.00 millionViewN/AView Earnings Details
7/27/2017Q2 2017($4.80)($4.40)$21.74 million$21.30 millionViewN/AView Earnings Details
4/27/2017Q1 2017($6.60)($7.50)$15.72 million$17.50 millionViewN/AView Earnings Details
3/8/2017Q4 2016($6.50)($4.80)$22.75 million$24.80 millionViewListenView Earnings Details
11/1/2016Q3 2016($5.90)($9.70)$23.42 million$12.29 millionViewN/AView Earnings Details
7/28/2016Q216($6.50)($6.00)$23.08 million$23.00 millionViewListenView Earnings Details
4/28/2016Q116($6.90)($6.80)$17.67 million$20.06 millionViewN/AView Earnings Details
2/24/2016Q415($5.10)($4.00)$29.17 million$29.10 millionViewListenView Earnings Details
10/29/2015Q3($8.00)($6.50)$12.58 million$15.70 millionViewListenView Earnings Details
7/30/2015Q215($7.10)($6.50)$14.92 million$15.70 millionViewListenView Earnings Details
4/30/2015Q115($7.90)($8.30)$12.19 million$12.30 millionViewN/AView Earnings Details
2/24/2015Q414($8.10)($7.80)$17.16 million$17.90 millionViewN/AView Earnings Details
11/6/2014Q314($8.20)($8.50)$13.60 million$13.50 millionViewN/AView Earnings Details
7/31/2014Q214($9.10)($8.30)$10.36 million$10.26 millionViewN/AView Earnings Details
5/6/2014Q1($6.90)($9.60)$8.24 million$8.10 millionViewN/AView Earnings Details
3/6/2014Q4 2013($13.10)($16.00)$8.64 million$10.25 millionViewN/AView Earnings Details
11/8/2011$2.50$1.80ViewN/AView Earnings Details
8/9/2011$2.60$2.00ViewN/AView Earnings Details
5/10/2011$2.40$2.40ViewN/AView Earnings Details
3/14/2011$2.90$1.80ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Tandem Diabetes Care (NASDAQ:TNDM) Earnings Estimates

2018 EPS Consensus Estimate: ($1.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.34)($0.34)($0.34)
Q2 20182($0.34)($0.28)($0.31)
Q3 20182($0.28)($0.28)($0.28)
Q4 20182($0.28)($0.20)($0.24)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Tandem Diabetes Care (NASDAQ:TNDM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Tandem Diabetes Care (NASDAQ TNDM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 20.90%
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Institutional Ownership by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ TNDM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2018Christopher J TwomeyDirectorBuy75,000$2.00$150,000.00View SEC Filing  
2/9/2018Kim D BlickenstaffCEOBuy750,000$2.00$1,500,000.00View SEC Filing  
10/13/2017Kim D BlickenstaffCEOBuy285,700$3.50$999,950.00View SEC Filing  
3/23/2017Kim D BlickenstaffCEOBuy1,600,000$1.25$2,000,000.002,007,939View SEC Filing  
8/1/2016John F SheridanEVPSell15,000$6.52$97,800.0022,763View SEC Filing  
5/2/2016John F SheridanCOOSell2,000$10.61$21,220.007,295View SEC Filing  
4/22/2016John F SheridanCOOSell2,000$10.00$20,000.007,295View SEC Filing  
3/7/2016John F SheridanCOOSell4,000$10.01$40,040.009,295View SEC Filing  
2/26/2016Dick AllenDirectorBuy10,000$8.24$82,400.00View SEC Filing  
12/1/2015John F. SheridanCOOSell2,000$10.14$20,280.004,084View SEC Filing  
11/2/2015John F. SheridanCOOSell4,000$10.00$40,000.004,084View SEC Filing  
9/14/2015John F. SheridanCOOSell2,000$12.51$25,020.004,084View SEC Filing  
5/1/2015John F SheridanCOOSell2,000$13.72$27,440.00View SEC Filing  
4/1/2015John F SheridanCOOSell2,000$12.47$24,940.00View SEC Filing  
2/2/2015John F SheridanCOOSell2,000$12.06$24,120.00View SEC Filing  
1/2/2015John F SheridanCOOSell2,000$12.75$25,500.00View SEC Filing  
12/12/2014Dick AllenDirectorBuy10,000$11.95$119,500.00View SEC Filing  
12/1/2014John F SheridanCOOSell2,000$13.55$27,100.00View SEC Filing  
11/3/2014John F SheridanCOOSell2,000$16.00$32,000.00View SEC Filing  
10/1/2014John F SheridanCOOSell2,000$13.07$26,140.00View SEC Filing  
9/2/2014John F SheridanCOOSell2,000$13.99$27,980.00View SEC Filing  
8/1/2014John F SheridanCOOSell2,000$15.04$30,080.00View SEC Filing  
7/1/2014John F SheridanCOOSell2,000$16.42$32,840.00View SEC Filing  
6/18/2014John F SheridanCOOSell2,000$16.75$33,500.00View SEC Filing  
11/13/2013David B BergerGeneral CounselBuy2,000$15.00$30,000.00View SEC Filing  
11/13/2013Hlm Venture Partners Ii, L.P.Major ShareholderBuy200,000$15.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tandem Diabetes Care (NASDAQ TNDM) News Headlines

Source:
DateHeadline
Tandem Diabetes Care Applies for Health Canada Medical Device License - Business Wire (press release)Tandem Diabetes Care Applies for Health Canada Medical Device License - Business Wire (press release)
www.businesswire.com - February 21 at 8:23 AM
BRIEF-Tandem Diabetes Care Applies For Health Canada Medical Device LicenseBRIEF-Tandem Diabetes Care Applies For Health Canada Medical Device License
www.reuters.com - February 20 at 5:45 PM
Tandem Diabetes file marketing application in Canada for t:slim X2 with G5Tandem Diabetes file marketing application in Canada for t:slim X2 with G5
seekingalpha.com - February 20 at 5:45 PM
Tandem Diabetes Care Applies for Health Canada Medical Device LicenseTandem Diabetes Care Applies for Health Canada Medical Device License
finance.yahoo.com - February 20 at 5:45 PM
Reduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Cares Pivotal Trial for the t:slim X2 Insulin Pump ... - Business Wire (press release)Reduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Care's Pivotal Trial for the t:slim X2 Insulin Pump ... - Business Wire (press release)
www.businesswire.com - February 17 at 8:14 AM
Tandem Diabetes Care Inc (TNDM) Expected to Announce Quarterly Sales of $36.10 MillionTandem Diabetes Care Inc (TNDM) Expected to Announce Quarterly Sales of $36.10 Million
www.americanbankingnews.com - February 16 at 11:06 AM
Tandem Diabetes inks distribution deal in ScandinaviaTandem Diabetes inks distribution deal in Scandinavia
seekingalpha.com - February 15 at 5:20 PM
Reduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Care’s Pivotal Trial for the t:slim X2 Insulin Pump with Predictive Low Glucose Suspend Feature; Data to be Presented at ATTD 2018 ConferenceReduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Care’s Pivotal Trial for the t:slim X2 Insulin Pump with Predictive Low Glucose Suspend Feature; Data to be Presented at ATTD 2018 Conference
finance.yahoo.com - February 15 at 5:20 PM
Tandem Diabetes Care and Rubin Medical Announce Agreement for Distribution of Insulin Pump Products in ScandinaviaTandem Diabetes Care and Rubin Medical Announce Agreement for Distribution of Insulin Pump Products in Scandinavia
finance.yahoo.com - February 15 at 5:20 PM
Tandem Diabetes Care Schedules Fourth Quarter and Full Year 2017 Earnings Press Release and Conference CallTandem Diabetes Care Schedules Fourth Quarter and Full Year 2017 Earnings Press Release and Conference Call
finance.yahoo.com - February 15 at 9:19 AM
Wednesday 2/14 Insider Buying Report: GLPI, TNDMWednesday 2/14 Insider Buying Report: GLPI, TNDM
www.nasdaq.com - February 14 at 4:16 PM
Tandem Diabetes Care Announces Closing of $69 Million Underwritten Public Offering of Common StockTandem Diabetes Care Announces Closing of $69 Million Underwritten Public Offering of Common Stock
finance.yahoo.com - February 14 at 9:52 AM
Tandem Diabetes Care Inc (TNDM) PRESIDENT & CEO Kim D Blickenstaff Bought $1.5 million of SharesTandem Diabetes Care Inc (TNDM) PRESIDENT & CEO Kim D Blickenstaff Bought $1.5 million of Shares
finance.yahoo.com - February 14 at 9:52 AM
Zacks: Analysts Anticipate Tandem Diabetes Care Inc (TNDM) to Post -$1.28 EPSZacks: Analysts Anticipate Tandem Diabetes Care Inc (TNDM) to Post -$1.28 EPS
www.americanbankingnews.com - February 14 at 1:08 AM
Tandem Diabetes Care Inc (TNDM) Director Christopher J. Twomey Acquires 75,000 SharesTandem Diabetes Care Inc (TNDM) Director Christopher J. Twomey Acquires 75,000 Shares
www.americanbankingnews.com - February 13 at 6:30 PM
Insider Buying: Tandem Diabetes Care Inc (TNDM) CEO Purchases 750,000 Shares of StockInsider Buying: Tandem Diabetes Care Inc (TNDM) CEO Purchases 750,000 Shares of Stock
www.americanbankingnews.com - February 13 at 6:10 PM
BDX’s Planned Product Launches in 2018BDX’s Planned Product Launches in 2018
finance.yahoo.com - February 13 at 3:44 PM
Tandem Diabetes (TNDM) Prices $60M Public Offering of Common Stock at $2/ShareTandem Diabetes (TNDM) Prices $60M Public Offering of Common Stock at $2/Share
www.streetinsider.com - February 9 at 3:56 PM
Tandem Diabetes Care Announces Pricing of $60 Million Underwritten Public Offering of Common StockTandem Diabetes Care Announces Pricing of $60 Million Underwritten Public Offering of Common Stock
finance.yahoo.com - February 9 at 9:54 AM
Tandem Diabetes prices stock offering at $2.00; shares down 26% premarketTandem Diabetes prices stock offering at $2.00; shares down 26% premarket
seekingalpha.com - February 9 at 9:28 AM
Tandem Diabetes Care Inc (TNDM) Receives Consensus Rating of "Hold" from BrokeragesTandem Diabetes Care Inc (TNDM) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - February 2 at 1:03 PM
Whats Happening With These Medical Supplies Stocks? -- Tandem Diabetes Care, Integra LifeSciences, OraSure ... - PR Newswire (press release)What's Happening With These Medical Supplies Stocks? -- Tandem Diabetes Care, Integra LifeSciences, OraSure ... - PR Newswire (press release)
www.prnewswire.com - February 2 at 9:31 AM
BRIEF-Tandem Diabetes Care Files For Offering Of 13.5 Mln Shares Of Cos Common StockBRIEF-Tandem Diabetes Care Files For Offering Of 13.5 Mln Shares Of Co's Common Stock
www.reuters.com - January 29 at 9:48 AM
Zacks: Analysts Anticipate Tandem Diabetes Care Inc (TNDM) to Post -$1.28 Earnings Per ShareZacks: Analysts Anticipate Tandem Diabetes Care Inc (TNDM) to Post -$1.28 Earnings Per Share
www.americanbankingnews.com - January 28 at 1:18 AM
Comparing Steris (STE) and Tandem Diabetes Care (TNDM)Comparing Steris (STE) and Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - January 27 at 3:32 AM
Tandem Diabetes Care (TNDM) Downgraded by Zacks Investment ResearchTandem Diabetes Care (TNDM) Downgraded by Zacks Investment Research
www.americanbankingnews.com - January 20 at 6:56 PM
BRIEF-Tandem Diabetes Care Files For Offering Of Up To $40 MlnBRIEF-Tandem Diabetes Care Files For Offering Of Up To $40 Mln
www.reuters.com - January 16 at 11:09 AM
34 Stocks Moving In Wednesdays Mid-Day Session34 Stocks Moving In Wednesday's Mid-Day Session
feeds.benzinga.com - January 10 at 12:57 PM
Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 GuidanceTandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance
finance.yahoo.com - January 10 at 11:13 AM
Tandem Diabetes (TNDM) Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump - StreetInsider.comTandem Diabetes (TNDM) Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump - StreetInsider.com
www.streetinsider.com - January 8 at 3:55 PM
Tandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study TimelineTandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study Timeline
finance.yahoo.com - January 8 at 3:55 PM
Tandem Diabetes Care Inc (TNDM) Given Average Recommendation of "Hold" by BrokeragesTandem Diabetes Care Inc (TNDM) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 8 at 8:38 AM
Tandem Diabetes Care (TNDM) Rating Increased to Buy at Zacks Investment ResearchTandem Diabetes Care (TNDM) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - January 6 at 7:02 AM
Tandem Diabetes Care (TNDM) Downgraded to "Hold" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - January 5 at 2:02 PM
Tandem Diabetes Care Commences Full Manufacturing Operations at New San Diego FacilityTandem Diabetes Care Commences Full Manufacturing Operations at New San Diego Facility
finance.yahoo.com - January 3 at 10:38 AM
Head to Head Comparison: Bio-Rad Laboratories (BIO) versus Tandem Diabetes Care (TNDM)Head to Head Comparison: Bio-Rad Laboratories (BIO) versus Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - December 31 at 9:30 AM
New Year to Bring Back MedTech Tax, 3 Stocks Unfazed - NasdaqNew Year to Bring Back MedTech Tax, 3 Stocks Unfazed - Nasdaq
www.nasdaq.com - December 27 at 11:49 AM
New Year to Bring Back MedTech Tax, 3 Stocks UnfazedNew Year to Bring Back MedTech Tax, 3 Stocks Unfazed
finance.yahoo.com - December 27 at 11:49 AM
Zacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Post Quarterly Sales of $34.36 MillionZacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Post Quarterly Sales of $34.36 Million
www.americanbankingnews.com - December 27 at 6:12 AM
Tandem Diabetes Care Inc (TNDM) Expected to Post Earnings of -$1.30 Per ShareTandem Diabetes Care Inc (TNDM) Expected to Post Earnings of -$1.30 Per Share
www.americanbankingnews.com - December 25 at 1:16 PM
Tandem Diabetes Care (TNDM) and Landauer (LDR) Critical ComparisonTandem Diabetes Care (TNDM) and Landauer (LDR) Critical Comparison
www.americanbankingnews.com - December 23 at 5:32 AM
Tandem Diabetes Care (TNDM) Raised to "Buy" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - December 20 at 5:56 PM
Where Tandem Diabetes Care Inc (NASDAQ:TNDM) Stands In Terms Of Earnings Growth Against Its IndustryWhere Tandem Diabetes Care Inc (NASDAQ:TNDM) Stands In Terms Of Earnings Growth Against Its Industry
finance.yahoo.com - December 19 at 3:49 PM
Comparing Palomar Medical Technologies (PMTI) & Tandem Diabetes Care (TNDM)Comparing Palomar Medical Technologies (PMTI) & Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - December 16 at 9:32 AM
Tandem Diabetes Care Announces Issuance of Patent Related to Automated Insulin Delivery TechnologyTandem Diabetes Care Announces Issuance of Patent Related to Automated Insulin Delivery Technology
finance.yahoo.com - December 14 at 11:22 AM
Tandem Diabetes Care Inc (TNDM) Receives Average Rating of "Hold" from AnalystsTandem Diabetes Care Inc (TNDM) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 14 at 8:42 AM
Tandem Diabetes Care (TNDM) Downgraded by Zacks Investment Research to HoldTandem Diabetes Care (TNDM) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - December 13 at 10:20 AM
Tandem Diabetes Care (TNDM) Upgraded to "Buy" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - December 10 at 6:28 AM
Zacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Announce Quarterly Sales of $34.36 MillionZacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Announce Quarterly Sales of $34.36 Million
www.americanbankingnews.com - December 9 at 2:44 AM
Tandem Diabetes Care Announces Retirement of CFO and ... - Business Wire (press release)Tandem Diabetes Care Announces Retirement of CFO and ... - Business Wire (press release)
www.businesswire.com - December 8 at 11:26 AM

SEC Filings

Tandem Diabetes Care (NASDAQ:TNDM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tandem Diabetes Care (NASDAQ:TNDM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tandem Diabetes Care (NASDAQ TNDM) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.